These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 31450540)
1. Correlation between CT based radiomics features and gene expression data in non-small cell lung cancer. Wang T; Gong J; Duan HH; Wang LJ; Ye XD; Nie SD J Xray Sci Technol; 2019; 27(5):773-803. PubMed ID: 31450540 [TBL] [Abstract][Full Text] [Related]
3. Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer. Gu Q; Feng Z; Liang Q; Li M; Deng J; Ma M; Wang W; Liu J; Liu P; Rong P Eur J Radiol; 2019 Sep; 118():32-37. PubMed ID: 31439255 [TBL] [Abstract][Full Text] [Related]
4. Non-Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications. Zhou M; Leung A; Echegaray S; Gentles A; Shrager JB; Jensen KC; Berry GJ; Plevritis SK; Rubin DL; Napel S; Gevaert O Radiology; 2018 Jan; 286(1):307-315. PubMed ID: 28727543 [TBL] [Abstract][Full Text] [Related]
5. Contrast Enhanced CT Radiogenomics in a Retrospective NSCLC Cohort: Models, Attempted Validation of a Published Model and the Relevance of the Clinical Context. Kohan A; Hinzpeter R; Kulanthaivelu R; Mirshahvalad SA; Avery L; Tsao M; Li Q; Ortega C; Metser U; Hope A; Veit-Haibach P Acad Radiol; 2024 Jul; 31(7):2953-2961. PubMed ID: 38383258 [TBL] [Abstract][Full Text] [Related]
6. A prognostic analysis method for non-small cell lung cancer based on the computed tomography radiomics. Wang X; Duan H; Li X; Ye X; Huang G; Nie S Phys Med Biol; 2020 Feb; 65(4):045006. PubMed ID: 31962301 [TBL] [Abstract][Full Text] [Related]
7. Measuring Computed Tomography Scanner Variability of Radiomics Features. Mackin D; Fave X; Zhang L; Fried D; Yang J; Taylor B; Rodriguez-Rivera E; Dodge C; Jones AK; Court L Invest Radiol; 2015 Nov; 50(11):757-65. PubMed ID: 26115366 [TBL] [Abstract][Full Text] [Related]
8. Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology. Tu W; Sun G; Fan L; Wang Y; Xia Y; Guan Y; Li Q; Zhang D; Liu S; Li Z Lung Cancer; 2019 Jun; 132():28-35. PubMed ID: 31097090 [TBL] [Abstract][Full Text] [Related]
9. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer. Chen X; Fang M; Dong D; Wei X; Liu L; Xu X; Jiang X; Tian J; Liu Z Acad Radiol; 2018 Dec; 25(12):1548-1555. PubMed ID: 29572049 [TBL] [Abstract][Full Text] [Related]
10. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer. Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009 [TBL] [Abstract][Full Text] [Related]
11. Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer. Tang X; Xu X; Han Z; Bai G; Wang H; Liu Y; Du P; Liang Z; Zhang J; Lu H; Yin H Biomed Eng Online; 2020 Jan; 19(1):5. PubMed ID: 31964407 [TBL] [Abstract][Full Text] [Related]
12. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics. Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876 [TBL] [Abstract][Full Text] [Related]
13. Associations between Radiomics and Genomics in Non-Small Cell Lung Cancer Utilizing Computed Tomography and Next-Generation Sequencing: An Exploratory Study. Ottaiano A; Grassi F; Sirica R; Genito E; Ciani G; Patanè V; Monti R; Belfiore MP; Urraro F; Santorsola M; Ponsiglione AM; Montella M; Cappabianca S; Reginelli A; Sansone M; Savarese G; Grassi R Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927739 [TBL] [Abstract][Full Text] [Related]
14. Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer. Fave X; Zhang L; Yang J; Mackin D; Balter P; Gomez D; Followill D; Jones AK; Stingo F; Liao Z; Mohan R; Court L Sci Rep; 2017 Apr; 7(1):588. PubMed ID: 28373718 [TBL] [Abstract][Full Text] [Related]
15. [Development of a radiomics signature to predict Ki-67 expression level in non-small cell lung cancer]. Gu Q; Feng Z; Liang Q; Li M; Wang W; Rong P Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 43(11):1216-1222. PubMed ID: 30643066 [TBL] [Abstract][Full Text] [Related]
16. Radiomic Detection of EGFR Mutations in NSCLC. Rossi G; Barabino E; Fedeli A; Ficarra G; Coco S; Russo A; Adamo V; Buemi F; Zullo L; Dono M; De Luca G; Longo L; Dal Bello MG; Tagliamento M; Alama A; Cittadini G; Pronzato P; Genova C Cancer Res; 2021 Feb; 81(3):724-731. PubMed ID: 33148663 [TBL] [Abstract][Full Text] [Related]
17. CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy. Yang F; Zhang J; Zhou L; Xia W; Zhang R; Wei H; Feng J; Zhao X; Jian J; Gao X; Yuan S Eur Radiol; 2022 Mar; 32(3):1538-1547. PubMed ID: 34564744 [TBL] [Abstract][Full Text] [Related]
18. CT-based radiomics signature to predict CD8+ tumor infiltrating lymphocytes in non-small-cell lung cancer. Chen Y; Xu T; Jiang C; You S; Cheng Z; Gong J Acta Radiol; 2023 Apr; 64(4):1390-1399. PubMed ID: 36120843 [TBL] [Abstract][Full Text] [Related]